The relationship of granzyme a and perforin expression to cardiac allograft rejection and dysfunction

Transplantation

Volumn 60, Issue 12, 1995, Pages 1478-1485

  Alpert, Susan ^a   Lewis, Neil P ^a,b   Ross, Heather ^a,c   Fowler, Michael ^a   Valantine, Hannah A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c Dalhousie Medical Research Foundation ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GRANZYME A; MESSENGER RNA; PERFORIN;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GRAFT REJECTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRANZYMES; HEART TRANSPLANTATION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; PREDICTIVE VALUE OF TESTS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029558549     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199560120-00019     Document Type: Article

References (57)

1. The Registry of the International Society for Heart and Lung Transplantation. Tenth official report. J Heart Lung Transplant 1993; 12: 543.
2. Johnson D, Alderman EL, Schroeder JS, et al. Transplant coronary disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991; 17: 449.
3. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994; 89: 2421.
4. Valantine HA. Rejection surveillance by Doppler echocardiography. J Heart Lung Transplant 1993; 12: 422.
5. Stevenson LW, Lewis W, McAlpin RN, Clark S. Acute reversible cardiogenic shock: immune-mediated with mild histologic change. Am Heart J 1986; 111: 611.
6. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54: 326.
7. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. Transplantation 1994; 57: 1333.
8. Hayry P, Defendi V. Mixed lymphocyte culture produce effector cells: model in vitro for allograft rejection. Science 1970; 168: 133.
9. Ascher NL, Hoffman R, Chen S, Simmons RL. Specific and non-specific infiltration of sponge matrix allografts by specifically sensitized cytotoxic lymphocytes. Cell Immunol 1980; 52: 38.
10. Hruban RH, Beschorner WE, Baumgartner WA, et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte mediated endothelium. Am J Pathol 1990; 137: 871.
11. Crammer DV, Chapman FA, Wu GD, Harnaha JB, Quian S, Makowa L. Cardiac transplantation in the rat: II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 1990; 50: 554.
12. Moraes JR, Stastny P. A new antigen system expressed in human endothelial cells. J Clin Invest 1977; 60: 449.
13. Claas FHJ, Paul LC, van Es LA, van Rood JJ. Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. Tissue Antigens 1980; 15: 19.
14. Hirschberg H, Evensen SA, Henriksen T, Thorsby E. The human mixed lymphocyte-endotheliurn culture interaction. Transplantation 1975; 19: 495.
15. Pober JS, Gimbrone MA Jr, Cotran RS, et al. Ia expression by vascular endothelium is inducible by activated T cells and by human γ interferon. J Exp Med 1983; 157: 1339.
16. McWhinnie DL, Thompson JF, Taylor HM, et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 1986; 42: 352.
17. Burdick JF, Beschorner WE, Smith WJ, et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679.
18. Burdick JF. The anatomy of rejection. Transplant Rev 1991; 5: 81.
19. Kiaer H, Hansen HE, Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 1980; 13: 58.
20. Cunningham DA, Dunn MJ, Yocoub MH, Rose ML. Local production of cytokines in the human cardiac allograft: a serial study. Transplantation 1994; 57: 1333.
21. Baan CC, Van Emmerik NEM, Balk AHMM, et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human transplants. Clin Exp Immunol 1994; 97: 293.
22. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990; 87: 2239.
23. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991; 12: 415.
24. Podack ER. Killer lymphocytes and how they kill. Curr Opinions Cell Biol 1989; 1: 929.
25. Berke G. Lymphocyte triggered internal target disintegration. Immunol Today 1991; 12: 369.
26. Gershenfeld HK, Weissman IL. Cloning of a cDNA for a T cell specific serine protease from a cytotoxic T lymphocyte. Science 1986; 232: 854.
27. Redelman D, Hudig D. The mechanism of cell mediated cytotoxicity I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases. J Immunol 1980; 124: 870.
28. Schmid J, Weissman C. Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen stimulated human leukocytes. J Immunol 1987; 139: 250.
29. Chang JV, Eisen H. Effects of N-tosyl-L-lysyl chloromethylene on the activity of cytotoxic T lymphocytes. J Immunol 1980; 124: 1028.
30. Liu CC, Rafii S, Granelli-Pipemo A, Trapani JA, Ding E, Young J. Perforin and serine esterase gene expression in stimulated human T cells. J Exp Med 1989; 170: 2105.
31. Burnet JF, Denzoit F, Susan M, et al. CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always. J Immunol 1987; 38: 4102.
32. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Ding E, Young J. Perforin and serine esterase gene expression in stimulated human T cells. J Exp Med 1989; 170: 2105.
33. Krahenbuhl OR C, Jeme P, Lanzaracchia A, Groscurth P, Carrel S, Tschopp J. Characterization of granzyme A and B isolated from granules of cloned human cytotoxic T lymphocytes. J Immunol 1988; 144: 3471.
34. Hameed AL D, Chesterfield M, Podak E. Characterization of the serine esterase isolated from human IL-2 activated killer cells. J Immunol 1988; 141: 3142.
35. Lichtenheld MG, Olsen KJ, La P, et al. Structure and function of human perforin. Nature 1988; 335: 448.
36. Martin DE, Zalman LS, Jung G, Muller-Eberhard HJ. Induction of synthesis of the cytolytic C9 (ninth component of complement)—related protein in human peripheral mononuclear cells by monoclonal antibody OXT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype. Proc Natl Acad Sci USA 1987; 84: 2946.
37. Garcia-Sanz JA, Velotti F, MacDonald HR, Masson D, Tschopp J, Nabholz M. Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli. Immunology 1988; 64: 129.
38. Griffiths G, Isaaz S. Granzyme A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J Cell Biol 1993; 110: 885.
39. Hayes MP, Berrebi GA, Henkart PA. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 1989; 170: 933.
40. Shiver JW, Henkart PA. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 1991; 64: 1175.
41. Talento A, Nguyen M, Law S, et al. Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity. J Immunol 1992; 149: 4009.
42. Griffiths GM, Namikawa R, Mueller C, et al. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991; 21: 687.
43. Mueller C, Shelby J, Weissman IL, Perinat-Frey T, Eichwald EJ. Expression of the protease gene HF as a marker in rejecting allogeneic murine heart transplants. Transplantation 1991; 51: 514.
44. Chen RH, Ivens KW, Alpert S, et al. The use of granzyme A as a marker of heart transplant rejection in cyclosporin A- or anti- CD4 monoclonal antibody-treated rats. Transplantation 1993; 55: 146.
45. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
46. Bugeon L, Cuturi M-C, Paineau J, Anegon I, Soulillou J-P. Similar levels of granzyme A and perforin mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 56: 405.
47. Billingham ME, Carey NRB, Hammond ME, Kemnitz J, Marboe C, McAllister HA. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
48. Chomozymski P, Sacchi N. Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
49. Lewis N, Tsao P, Rickenbacher P, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation, in press.
50. Chen RH, Fuggle SV. In situ cDNA polymerase chain reaction: a novel technique of detecting mRNA expression. Am J Pathol 1993; 143: 1527.
51. Alpert S, Kang HI, Weissman I, Fox RI. Expression of granzyme A in salivary gland biopsies from patients with primary Sjogren’s syndrome. Arthritis Rheumatism 1994; 37: 1046.
52. Valantine H, Yeoh TK, Gibbons R, et al. Sensitivity and specificity of diastolic indices for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991; 10: 757.
53. Valantine HA, Appleton LK, Hatle SA, Stinson EB, Popp RL. Influence of recipient atrial contraction on left ventricular filling dynamics on the transplanted heart assessed by Doppler echocardiography. Am J Cardiol 1987; 59: 1159.
54. Valantine HA, Appleton CK, Hatle LA, Stinson EB, Popp RL. Variability of Doppler echocardiographic indices of left ventricular filling in transplant recipients and normal subjects. J Am Soc Echocardiogr 1990; 3: 276.
55. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072.
56. Rizeq MN, Masek MA, Billingham ME. Acute rejection: significance of elapsed time after transplantation. J Heart Lung Transplant 1994; 13: 862.
57. Chen R. Cellular infiltration in transplanted organs: detection of cytotoxic granule-associated proteins. Doctoral dissertation, Oxford, UK: University of Oxford, 1994.